Professor Greg Schultz
University of Florida
Dr. Gregory Schultz received a PhD in Biochemistry from Oklahoma State University in 1976 then completed three years of post-doctoral study in Cell Biology at Yale University. He was appointed Assistant Professor of Biochemistry at the University of Louisville, School of Medicine in 1979, and was promoted to Associate Professor of Biochemistry and Ophthalmology in 1985. In 1989, Dr. Schultz was appointed Professor of Ob/Gyn at the University of Florida where he established the Institute for Wound Research to study molecular and cellular regulation of healing. Dr. Schultz’s research focuses on the roles of growth factors, cytokines and proteases in normal and chronic wound healing in skin and eye. He has published more than 250 research papers, chapters and review articles, which have been cited more than 6,500 times, and he has over a dozen patents in the area of wound healing that serve as the intellectual property foundation for two biotech companies he has helped to launch. He is a Principle Investigator or Co-Investigator on research grants totalling over US$30 million from the National Institutes of Health and pharmaceutical companies, and he is a consultant for multiple biotechnology companies. He was recognised as an Innovation Leader by TIME magazine in 2006. He is the Chair of the Wound Bed Preparation Advisory Board, a member of the National Pressure Ulcer Advisory Panel, and he served as President of the Wound Healing Society from 1999-2001. He has served as the primary advisor for over 20 PhD or MS graduate students and trained more than 15 post-doctoral associates. He was awarded a Medicine Doctorate degree from Linkoping University, Sweden in 1996, and he received the Basic Science Research Award from the University of Florida, College of Medicine in 2008. He was recognised as the International Educator of the Year for the College of Medicine in 2008, and he was recognised as an Exemplary Educator in the College of Medicine in 2009.
Dr Giuseppe Trigiante
Queen Mary University of London
Dr. Giuseppe Trigiante was awarded his PhD in Biophysical Chemistry by Stanford university in 1999. After a brief experience with cancer research in academia he turned to the private sector taking a position as Head of Research at a London pharmaceutical start-up, Lokpal Limited. During the course of this appointment he developed and patented a novel topical form of photodynamic therapy for skin cancers. Subsequently, Dr. Trigiante worked as consultant to another biotech start-up, Yagna limited, directing research on a new biocompatible waterproof coating for cellulose based packaging materials. This work resulted in another international patent on a biodegradable coating process for cellulose. Since 2014, he has worked with the Phoenix Eagle Company on their patented papaya extract OPAL-A and related cysteine protease debriding technology. Dr. Trigiante describes his work as the interface between industry and academic research focussing on translating scientific knowledge into applied technology.
Professor Geoff Mitchell
University of Queensland
Geoff Mitchell is Professor of General Practice and Palliative Care, and head of the MBBS Program at Ipswich, Queensland. Professor Mitchell's main research interest is in the role of General Practitioners in palliative care. His other research interests are in GP management of chronic and complex conditions including Pain and Attention Deficit Hyperactivity Disorder, and in quality issues in General Practice. He has authored over 140 refereed journal articles, as well as numerous book chapters and reports in these and other areas of clinical general practice. He was awarded his PhD in May 2005.
He was involved in the development of a Hospice and a regional palliative care network in Ipswich and was the inaugural Director of the Centre for Palliative Care Research and Education. In 2008, he authored a book entitled ``Palliative care: a patient centred method``. He has co-authored clinical handbooks of Palliative Care entitled ``The Blue Book of Palliative Care``, and ``Therapeutics Guidelines: Palliative care``, and a national report into the palliative care education and support needs of GPs in palliative care. He maintains a clinical general practice in Ipswich, Queensland. He also heads a research program utilising n-of-1 trial design for the evaluation of treatments in patient groups with small numbers, or people who are difficult to retain in more standard treatment trials.